Ardelyx
Clinical trials sponsored by Ardelyx, explained in plain language.
Biopharmaceutical company developing treatments for gastrointestinal and kidney diseases.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Could this pill ease tummy troubles for kids with IBS-C?
Symptom relief OngoingThis study tests a medicine called tenapanor in children aged 6 to 12 who have irritable bowel syndrome with constipation (IBS-C). The goal is to see if it safely improves bowel movements and reduces belly discomfort. About 72 children will receive either the drug or a placebo fo…
Phase: PHASE2 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New drug tested for kids with chronic constipation
Symptom relief ENROLLING_BY_INVITATIONThis study is testing the long-term safety of tenapanor (Ibsrela) in children aged 6 to 17 with irritable bowel syndrome with constipation (IBS-C). About 150 kids who completed a prior study will continue taking the drug for up to one year. Researchers will monitor side effects a…
Phase: PHASE3 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New drug could ease teen IBS constipation pain
Symptom relief OngoingThis phase 3 trial tests tenapanor, a drug that helps with constipation and belly pain, in 180 teenagers aged 12 to 17 with irritable bowel syndrome and constipation (IBS-C). Participants take either a low or high dose of tenapanor or a placebo twice daily for 12 weeks. The goal …
Phase: PHASE3 • Sponsor: Ardelyx • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC